FIELD: medicine.
SUBSTANCE: invention includes a haemostatic composition comprising chitosan, according to the invention additionally contains epsilon aminocaproic acid, and chitosan and epsilon aminocaproic acid are taken in weight ratios of 8.0-12.0:1.0, respectively.
EFFECT: invention provides an increase in procoagulant and fibrin polymerization activity.
1 cl, 2 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR OBTAINING HEMOSTATIC COMPOSITION | 2021 |
|
RU2790831C2 |
| METHOD FOR PRODUCTION OF HEMOSTATIC COMPOSITION | 2021 |
|
RU2781788C2 |
| METHOD FOR MODELING CHRONIC TOXIC COAGULOPATHY IN EXPERIMENTAL ANIMALS | 2017 |
|
RU2661722C1 |
| METHOD OF NORMALISATION OF DISTURBANCES IN COAGULATION LINK OF HEMOSTASIS SYSTEM IN EXPERIMENT | 2009 |
|
RU2391713C1 |
| METHOD FOR SIMULATING CHROMIUM-INDUCED COAGULOPATHY IN EXPERIMENTAL RATS | 2020 |
|
RU2743812C1 |
| METHOD OF MODELING OF CHRONIC COAGULOPATHY IN EXPERIMENTAL ANIMALS | 2020 |
|
RU2746831C1 |
| USE OF INDICATORS OF COAGULATION HEMOSTASIS IN COMPREHENSIVE PHYSICAL EXAMINATION OF HIGHLY PRODUCTIVE CATTLE | 2022 |
|
RU2809362C1 |
| METHOD FOR PREVENTION OF CHRONIC TOXIC COAGULOPATHY IN EXPERIMENTAL ANIMALS | 2018 |
|
RU2683723C1 |
| METHOD OF DETERMINING INDICATIONS FOR TRANSFUSION OF PLASMA-COAGULATION HAEMOSTASIS CORRECTORS IN CARDIAC SURGERY | 2014 |
|
RU2568581C1 |
| METHOD FOR DETECTING FUNCTIONAL STATE OF HEMOSTATIC SYSTEM IN PATIENTS OF ELDERLY AND SENILE AGE | 2002 |
|
RU2263471C2 |
